0.9% Sodium Chloride Injection, USP - 2.5 mL in 3 mL Syringe, 0.9% Sodium Chloride Injection, USP-3mL in 10 mL Syringe, 0.9% Sodium Chloride Injection, USP - 5 mL in 10 mL Syringe, 0.9% Sodium Chloride Injection, USP - 10 mL in 10 mL Syringe
by Excelsior Medical Corporation
510(k) K142620
Active
Valid until
No expiry
FDA recalls
None ongoingDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK142620 | Date12 Dec 2014 | StatusActive |
Recalls
-
- Terminated Z-2948-2018
Packaged with an incorrect overwrap.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- NGT
- Device Class
- Class II
- Regulation
- 21 CFR Part 880.5200
- Advisory Committee
- General Hospital
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 19 Sep 2026
This device is a sterile, isotonic Saline, Vascular Access Flush (OpenFDA classification) designed for intravenous administration. It provides a physiologically compatible solution of 0.9% sodium chloride in water for injection, intended to maintain vascular access patency, flush catheters, or serve as a diluent for compatible parenteral medications.
Supplied as single-use, prefilled syringes in volumes of 2.5 mL (3 mL syringe), 3 mL (10 mL syringe), 5 mL (10 mL syringe), and 10 mL (10 mL syringe), the solution is non-pyrogenic and sterile-filtered. It is classified as a Class II device under FDA regulations (21 CFR 880.5200) and holds a FDA 510(k) clearance (K142620) for general hospital use. Storage requires protection from light and contamination, adhering to standard parenteral product handling protocols.